Security key
89680M119
TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (TLSIW)
CUSIP: 89680M119
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / *W EXP 08/10/202
- Total 13F shares
- 974,267
- Total 13F value
- $1,084,417
- Share change
- +782,511
- SEC-reported price per share
- $1.10
- Number of holders
- 8
- Value change
- +$862,956
- Number of buys
- 2
- Number of sells
- 5
Report period
Q4 2024
Institutions
8
Top holders
8
TLSIW full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
TriSalus Life Sciences, Inc. SEC filings
TriSalus Life Sciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89680M119
Recent filing periods:
Ownership snapshot
Top reported holders of TLSIW - TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MedTech Acquisition Spons...
Disclosed value leader
MedTech Acquisition Spons...
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5
13F
Highest disclosed value: $65,538,115
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
MedTech Acquisition Sponsor LLC has the largest disclosed position value at $65.54M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MedTech Acquisition Sponsor LLC's linked filing trail.
Disclosed position value
Top 5
MedTech Acquisition Sponsor LLC
$65.54M
Magnetar Financial LLC
$174.8K
Wealthcare Advisory Partners LLC
$2.97M
Duquesne Family Office LLC
$1.97M
VANGUARD GROUP INC
$1.92M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MedTech Acquisition Sponsor LLC |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$65,538,115
6,250,000 shares
mixed-class rows
|
— | 26 Jun 2023 |
| Magnetar Financial LLC |
3/4/5
13F
10%+ Owner · Company
|
—
denominator unverified
|
$174,782
16,668 shares
|
— | 12 Jun 2023 |
| Wealthcare Advisory Partners LLC |
13F
Company
|
—
denominator unverified
|
$2,967,641
643,740 shares
|
— | 30 Sep 2024 |
| Duquesne Family Office LLC |
13F
Company
|
—
denominator unverified
|
$1,968,000
426,921 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$1,918,396
416,138 shares
|
— | 30 Sep 2024 |
| George Kelly Martin |
3/4/5
Director
|
—
mixed-class rows
|
$1,359,468
262,176 shares
mixed-class rows
|
— | 28 Aug 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
974,267
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q1 2026 Across Filers
Q1 2026 holders
7
Q4 2024 holders
8
Holder diff
1
| Investor | Q1 2026 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend